mhsrs background image.jpg

Featured Speakers

Microsoft Michael.jpg

Michael Uohara, M.D.

Microsoft Corporation

Michael Y. Uohara, MD is the current Chief Medical Officer of Microsoft Federal at the Microsoft Corporation where he leads efforts in digital transformation within the Federal Healthcare sector. Prior to joining Microsoft, Dr. Uohara was Managing Director of the HealthShare Exchange’s (Pennsylvania’s, and one of the nation’s largest HIEs) MarketStreet platform (HSX MarketStreet) where he focused on bringing value to patients and healthcare systems by increasing the accessibility, usability, and interoperability of healthcare data.

Session: Visions of the Future. Operational Medicine Today, Tomorrow, and Beyond (Monday, 12 September | 1740 – 1800)

Danielle Micciantuono, MSN, RN

Microsoft Corporation

Danielle Micciantuono, MSN, RN is the current Industry Advisor of Microsoft Federal at the Microsoft Corporation where she supports efforts in digital transformation within the Federal Healthcare sector in direct support of the Chief Medical Officer. Prior to joining Microsoft, Ms. Micciantuono was supporting federal healthcare sales as a business development/ clinical advisor for both large and small businesses assisting in support of government healthcare programs.

Session: Visions of the Future. Operational Medicine Today, Tomorrow, and Beyond (Monday, 12 September | 1740 – 1800)

Microsoft  Danielle.jpg
Dr Weis.jpg

Karen Weis, Ph.D.

University of Kansas Medical Center, Salina, KS

Session: Prenatal Mentoring Intervention Fosters Improved Pregnancy Outcomes at Three Major Military Installations
(Thursday, 15 September | 1112 – 1125)

Elizabeth Kostas-Polston, Ph.D., APRN

Uniformed Services University, Bethesda, MD

Session: Intentions, Perceptions, and Behaviors of U.S. Army Female Warfighters at Risk of Urogenital Infections in Seeking Access of Water, Sanitation, and Medical Care in Operational Settings

(Thursday, 15 September | 1138 – 1151)

dr polston.jpg
adit ginde MD.jpg

Adit A. Ginde, M.D., MPH

Professor, Emergency Medicine and Anesthesiology

Vice Chair for Research, Department of Emergency Medicine

Medical Director, Clinical Research, Department of Anesthesiology

Trial Innovation Network Director, Colorado CTSI

Principal Investigator, ATLAS Research Program, University of Colorado School of Medicine

Dr. Ginde has been extensive funded by NIH and the U.S. Department of Defense to lead translational and pivotal clinical trials in critical illness and injury, focusing on early interventions for acute respiratory failure, respiratory infection, and sepsis. His research spans the emergency department, inpatient ward, intensive care unit, and perioperative settings. Dr. Ginde has been a leader in the NHLBI PETAL Network (prevention and treatment of ARDS), NHLBI CONNECTS (COVID-19 steering committee), and trans-NIH ACTIV program (COVID-19 clinical trials). In addition, he has led federally funded trials in airway management, pneumonia (including COVID-19), sepsis, and ARDS and has published over 240 peer-reviewed research articles in leading medical journals.

Session: Using Real World Data to Inform Ongoing Decisions on COVID Therapeutics (Monday, 12 September | 1600 – 1620)

Lt Col Ian J. Stewart, USAF, MC

Professor of Medicine, Uniformed Services University Director, Division of Nephrology, Bethesda, Maryland

Dr. Stewart has extensive experience with extracorporeal therapies both in the deployed environment and at home station. He has published extensively on acute kidney injury in the military setting and has done translational work on renal replacement therapy, extra-corporeal membrane oxygenation, and novel hemoperfusion systems. He is the principal investigator of the PURIFY-RCT protocol.

Session: Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19 (Monday, 12 September | 1620 – 1640)

Lt Col Ian J. Stewart.jpg
Simon D. Pollett.jpg

Simon D. Pollett, M.D., MBBS

Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland

Dr. Simon Pollett is a physician-scientist with research interests in the epidemiology and countermeasure development for epidemic respiratory and mosquito-borne viruses. His prior experience includes clinical infectious diseases, tropical medicine, vaccine development and translational viral genomics. His research background includes positions at the University of California at San Francisco, WRAIR Viral Diseases Branch, and US Naval Medical Research Unit No 6 in addition to a senior post-doctoral fellowship through the National Academies NRC Research Associateship Program.

Session: Insights into Pandemic Research and Response through EPICC and Other IDCRP Studies
(Monday, 12 September | 1640 – 1700)